Design, synthesis, biological evaluation and molecular docking of alkoxyaurones as potent pancreatic lipase inhibitors

Aurones are a minor subgroup of Flavonoids. Unlike other subgroups such as Chalcones, Flavones, and Isoflavones, aurones have not been extensively explored as pancreatic Lipase inhibitors. In this work, we studied the pancreatic Lipase inhibitory potency of synthetic aurone derivatives. Thirty-six compounds belonging to four series (4,6-dihydroxyaurone, 6-hydroxyaurone, 4,6-dialkoxyaurone, and 6-alkoxyaurone) were designed and synthesized. Their in vitro inhibitory activities were determined by spectrophotometric assay in comparison with quercetin and orlistat. Alkoxyaurone derivatives with long-chain (6-10 carbons) alkoxy substituents showed greater potency. Of them, 4,6-dialkoxyaurone 8 displayed the highest activity against pancreatic Lipase (IC₅₀ of 1.945 ± 0.520 µM) relative to quercetin (IC₅₀ of 86.98 ± 3.859 µM) and orlistat (IC₅₀ of 0.0334 ± 0.0015 µM). Fluorescence quenching measurement confirmed the affinity of alkoxyaurone derivatives to pancreatic Lipase. Kinetic study showed that 8 inhibited Lipase through a competitive mechanism (K_i of 1.288 ± 0.282 µM). Molecular docking results clarified the role of long-chain substituents on ring A in interacting with the hydrophobic pockets and pushing the inhibitor molecule closer to the catalytic triad. The findings in this study may contribute to the development of better pancreatic Lipase inhibitors with aurone structure.

Anti-obesity; Aurone; Flavoinoids; Pancreatic lipase inhibition.